Our ability to meld sector-specialised regulatory expertise with our exceptional transactional skills has made us uniquely suited to represent you in complicated transactions within the life sciences ecosystem.
Mergers and Acquisitions
Our M&A team is at the heart of our firm, and we act on some of the most complicated M&A deals in Life Sciences in India. We have advised clients on public and private M&A, court-approved mergers, joint ventures, restructuring, corporate governance, and regulatory compliance and have a particular focus on complicated cross-border deals. We provide advice in a broad range of areas, including Directors’ duties and responsibilities, Board formation, contingency planning, takeover defense, corporate governance, and director incentivisation and indemnification.
Advised one of India’s largest cosmetic ingredients and extracts manufacturers on a USD 100 Million sale of its business to OmniActive Health Technologies.
Assisted one of India’s largest chemical manufacturing companies on its acquisition of a company engaged in the manufacture and sale of lithium-based and other organolithium products.
Advised one of Singapore’s leading health-tech platforms on its acquisition by an Indian company, taking into consideration the domestic tax regimes in both countries, as well as the Singapore-India Double Taxation Avoidance Agreements.
Advised an affiliate of India’s second-largest pharmaceutical company on over 10 control acquisitions, in 2021 and 2022.
Advised a publicly listed American health services giant on a USD 300 Million acquisition of a leading Indian drug and nutraceuticals manufacturer.
Key Experts
Mathew
Chacko
Chacko
Praveen
Raju
Raju
Renuka
Abraham
Abraham
Swarna
Jain
Jain
